Hyponatremia in Heart Failure.
Clicks: 317
ID: 18084
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
63.2
/100
317 views
234 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #8 of 17 articles by views in internal medicine journal
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Hyponatraemia is common in heart failure (HF). It is estimated that over 20% of patients admitted to hospital with HF have hyponatraemia (1). It has also been repeatedly shown to be a surrogate marker of increased morbidity and mortality in this specific population (2). This review focuses on the pathophysiology of hyponatraemia through the activation of neurohormonal cascades in HF, the clinical implications of sustained hyponatraemia, as well as treatment options in the management of this challenging phenomenon. This article is protected by copyright. All rights reserved.
| Reference Key |
tee2019hyponatremiainternal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Tee, Su Ling;Sindone, Andrew;Roger, Simon;Atherton, John;Amerena, John;D'Emden, Michael;Erlich, Jonathan;De Pasquale, Carmine; |
| Journal | internal medicine journal |
| Year | 2019 |
| DOI |
10.1111/imj.14624
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.